Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SK Biopharmaceuticals
Pharma
Hengrui, Sanofi and Aslan—Fierce Pharma Asia
Hengrui got an FDA warning letter. Sanofi invests in its global capacity center in India. Singapore biotech Aslan Pharma winds down.
Angus Liu
Jul 19, 2024 9:48am
SK Biotek earmarks $35M to expand its Irish API production plant
Jun 16, 2022 9:20am
Takeda, Merck, SK Biopharm and more—Fierce Pharma Asia
Nov 12, 2021 9:20am
BioNTech-Fosun, Samsung Biologics and more—Fierce Pharma Asia
Dec 18, 2020 9:15am
SK Biopharmaceuticals preps for $850M IPO: FT
Nov 25, 2019 10:53am
Former Sanofi and BMS plants in EU reopened by Asian drugmakers
Jan 30, 2018 9:06am
